Acadia Pharmaceuticals (ACAD) Interest Expenses (2018 - 2019)

Acadia Pharmaceuticals (ACAD) recorded quarterly Interest Expenses of $12000.0 in Q2 2019, down 94.76% quarter-over-quarter from $229000.0 in Q1 2019, and down 95.14% on a YoY basis from $247000.0 in Q2 2018.

Acadia Pharmaceuticals (ACAD) Interest Expenses (2018 - 2019) Analysis & Trends

Acadia Pharmaceuticals' Interest Expenses history runs 2 years deep, the most recent figure standing at $12000.0 for Q2 2019.

  • In Q2 2019, Interest Expenses fell 95.14% year-over-year to $12000.0; the TTM figure through Mar 2020 stood at $12000.0 (down 99.42% YoY), while the FY2018 annual figure was $1.8 million, changed N/A from the prior year.
  • Interest Expenses was $12000.0 for Q2 2019 at Acadia Pharmaceuticals, down from $229000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $1.7 million in Q3 2018 to a low of -$127000.0 in Q4 2018.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -5.50 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -332,000.00
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 61,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -2,753.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -5.58 Mn
10 Acadia Pharmaceuticals 3.68 Bn 2.83 Bn 243.27 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2019 12,000.00
Jun 30, 2019 12,000.00
Mar 31, 2019 229,000.00
Mar 31, 2019 229,000.00
Dec 31, 2018 -127,000.00
Dec 31, 2018 -127,000.00
Sep 30, 2018 1.72 Mn
Sep 30, 2018 1.72 Mn
Jun 30, 2018 247,000.00
Jun 30, 2018 247,000.00